ArticleComplications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles
Section snippets
Daniel Bodri studied medicine at Semmelweis University, Budapest before specializing in Obstetrics and Gynecology in Hungary. Following a 1–year fellowship at the Public Hospitals of Paris, he trained at the Assisted Reproduction Unit of Jean Rostand Hospital, Sèvres in France. In 2004 he moved to Barcelona, Spain to work in a private infertility centre. His current research interests include various aspects of oocyte donation and the use of GnRH antagonists for donor stimulation protocols.
References (39)
- et al.
Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates
Fertility and Sterility
(2006) - et al.
Gonadotrophin-releasing hormone antagonists for assisted conception: aCochrane review
Reproductive BioMedicine Online
(2007) - et al.
Massive retroperitoneal bleeding: a complication of transvaginal ultrasonography-guided oocyte retrieval for in vitro fertilization-embryo transfer
Fertility and Sterility
(2000) - et al.
Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization
Fertility and Sterility
(2001) - et al.
Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer
Fertility and Sterility
(1993) - et al.
Thrombocythemia and hemoperitoneum after transvaginal oocyte retrieval for in vitro fertilization
Fertility and Sterility
(2004) - et al.
Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer
European Journal of Obstetrics, Gynecology, and Reproductive Biology
(1998) - et al.
A case of severe ovarian hyperstimulation in a healthy oocyte donor
Fertility and Sterility
(1995) Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome
Fertility and Sterility
(2004)- et al.
Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research
Reproductive BioMedicine Online
(2005)
Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval
American Journal of Obstetrics and Gynecology
Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases
American Journal of Obstetrics and Gynecology
Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy
Reproductive BioMedicine Online
Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors
International Journal of Gynaecology and Obstetrics
Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles
Fertility and Sterility
Perforated appendicitis and ectopic pregnancy following in-vitro fertilization
Human Reproduction
Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach
Acta Obstetricia et Gynecologica Scandinavica
Severe intraabdominal bleeding after transvaginal oocyte retrieval for IVF–ET and coagulation factor XI deficiency: a case report
Journal of Assisted Reproduction and Genetics
Complications of transvaginal ultrasound-directed follicle aspiration: a review of 2670 consecutive procedures
Journal of Assisted Reproduction and Genetics
Cited by (138)
Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline
2024, Fertility and SterilityOvarian torsion during ovarian stimulation prior to trigger followed by successful oocyte retrieval: A case report
2023, Case Reports in Women's HealthThe mild stimulation in vitro fertilization protocol
2023, Handbook of Current and Novel Protocols for the Treatment of InfertilityPerception of pain and the oocyte donor experience: a retrospective analysis of commercial US donors
2022, Reproductive BioMedicine OnlineCitation Excerpt :Donation may have only minor medical or psychological consequences, but more data are needed to ensure fully informed consent and possibly to protect donor health.’ Bodri et al. (2008) reported complications from 4052 donor oocyte cycles and found that 17 women were hospitalized in the process, with two of these women requiring hospitalization for pain management without another diagnosis. Kenney et al. (2010) found that donors’ reported awareness of the short-term effects from retrieval was low for all potential consequences.
Maximizing live birth rates cannot be the only key performance indicator of IVF
2022, Reproductive BioMedicine OnlineOocyte or embryo number needed to optimize live birth and cumulative live birth rates in mild stimulation IVF cycles
2021, Reproductive BioMedicine Online
Daniel Bodri studied medicine at Semmelweis University, Budapest before specializing in Obstetrics and Gynecology in Hungary. Following a 1–year fellowship at the Public Hospitals of Paris, he trained at the Assisted Reproduction Unit of Jean Rostand Hospital, Sèvres in France. In 2004 he moved to Barcelona, Spain to work in a private infertility centre. His current research interests include various aspects of oocyte donation and the use of GnRH antagonists for donor stimulation protocols.
Declaration: The authors report no financial or commercial conflicts of interest.